BIOMAT Database Logo BIOMAT Database Logo

[A case of agranulocytosis following use of thio-TEPA]. 1972

O G Vagina, and A K Vasiliev

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D013852 Thiotepa A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed). Thio-Tepa,Thiophosphamide,Triethylenethiophosphoramide,AI3-24916,Girostan,NSC-6396,Tespa,Tespamin,Tris(1-aziridinyl)phosphine Sulfide,AI3 24916,AI324916,NSC 6396,NSC6396,Thio Tepa
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

O G Vagina, and A K Vasiliev
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.
January 1990, Cancer chemotherapy and pharmacology,
O G Vagina, and A K Vasiliev
Renal failure associated with the use of thio-tepa.
November 1973, The Journal of urology,
O G Vagina, and A K Vasiliev
[Synoviorthesis by thio-tepa].
January 1968, Revue du rhumatisme et des maladies osteo-articulaires,
O G Vagina, and A K Vasiliev
"Thio-tepa" eye drops.
January 1970, Transactions of the Australian College of Ophthalmologists,
O G Vagina, and A K Vasiliev
Use of triethylene thio-phosphoramide (thio-TEPA) in treatment of advanced carcinoma of prostate.
January 1958, Transactions. American Urological Association. Western Section,
O G Vagina, and A K Vasiliev
[Teratogenic effect of thio-tepa despite use of safety rules].
October 1988, Ugeskrift for laeger,
O G Vagina, and A K Vasiliev
[Depression of bone marrow after intravesical use of Thio-tepa].
September 1980, Ugeskrift for laeger,
O G Vagina, and A K Vasiliev
Topical use of Thio-Tepa for tumours of the bladder.
January 1965, Urologia internationalis,
O G Vagina, and A K Vasiliev
The use of thio-tepa (triethylene thiophosphoramide) in melanotic sarcoma.
August 1957, Canadian Medical Association journal,
O G Vagina, and A K Vasiliev
Severe pancytopenia associated with the use of intravesical thio-TEPA.
October 1967, The Journal of urology,
Copied contents to your clipboard!